Cargando…

Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children

BACKGROUND: Poliomyelitis is an acute viral infection caused by poliovirus and transmitted via the fecal–oral route. The causative agent is one of the three serotypes of poliovirus (serotypes 1, 2, 3) that differ slightly in capsid protein. Prolonged vaccine-related poliovirus shedding in human immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassan, Joanne, Wangai, Laura, Borus, Peter, Khayeka–Wandabwa, Christopher, Karani, Lucy Wanja, Kithinji, Mercy, Kiptoo, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5670520/
https://www.ncbi.nlm.nih.gov/pubmed/29100529
http://dx.doi.org/10.1186/s13104-017-2843-y
_version_ 1783276045852475392
author Hassan, Joanne
Wangai, Laura
Borus, Peter
Khayeka–Wandabwa, Christopher
Karani, Lucy Wanja
Kithinji, Mercy
Kiptoo, Michael
author_facet Hassan, Joanne
Wangai, Laura
Borus, Peter
Khayeka–Wandabwa, Christopher
Karani, Lucy Wanja
Kithinji, Mercy
Kiptoo, Michael
author_sort Hassan, Joanne
collection PubMed
description BACKGROUND: Poliomyelitis is an acute viral infection caused by poliovirus and transmitted via the fecal–oral route. The causative agent is one of the three serotypes of poliovirus (serotypes 1, 2, 3) that differ slightly in capsid protein. Prolonged vaccine-related poliovirus shedding in human immunodeficiency virus (HIV) positive individuals has been linked to possible reservoir for reintroduction of polioviruses after eradication. The study therefore aimed at estimating the duration for vaccine-related poliovirus shedding among potentially and HIV-infected persons. METHODS: Poliovirus excretion was studied following vaccination of children aged ≤ 59 month per human immunodeficiency virus status after national immunization days. Their medical records were reviewed to identify the child’s HIV status, demographic and immunization data. Sequential stool samples were collected at site 2nd, 4th and 8th week after trivalent oral poliovirus vaccine (tOPV) was administered. To isolate suspected polioviruses and non-polio enteroviruses, characterize poliovirus subtypes by intratypic differentiation and Sabin vaccine derived poliovirus, real time polymerase chain reaction was applied. Shedding for ≥ 24 weeks was defined as long-term persistence. RESULTS: The mean age of the study population was 28.6 months, while the median age was 24 months. Of the children recruited, majority were in the 25–48 months (n = 12; 46.2%) age category. All the HIV-positive children (n = 10) had mild symptomatic HIV status and did shed vaccine-related polioviruses between weeks 2 and 4 respectively. No participant shed polioviruses for ≥ 6 weeks. CONCLUSIONS: It was evident mildly symptomatic HIV+ children sustain the capacity to clear vaccine-related poliovirus. The oral poliovirus vaccine-2 (Sabin like) that was detected in one HIV-infected child’s stool 6 weeks after the national immunization days was predominantly non revertant. There was no evident prolonged poliovirus shedding among the participants enlisted in the present study. High powered studies are desired to further corroborate these findings.
format Online
Article
Text
id pubmed-5670520
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56705202017-11-15 Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children Hassan, Joanne Wangai, Laura Borus, Peter Khayeka–Wandabwa, Christopher Karani, Lucy Wanja Kithinji, Mercy Kiptoo, Michael BMC Res Notes Research Article BACKGROUND: Poliomyelitis is an acute viral infection caused by poliovirus and transmitted via the fecal–oral route. The causative agent is one of the three serotypes of poliovirus (serotypes 1, 2, 3) that differ slightly in capsid protein. Prolonged vaccine-related poliovirus shedding in human immunodeficiency virus (HIV) positive individuals has been linked to possible reservoir for reintroduction of polioviruses after eradication. The study therefore aimed at estimating the duration for vaccine-related poliovirus shedding among potentially and HIV-infected persons. METHODS: Poliovirus excretion was studied following vaccination of children aged ≤ 59 month per human immunodeficiency virus status after national immunization days. Their medical records were reviewed to identify the child’s HIV status, demographic and immunization data. Sequential stool samples were collected at site 2nd, 4th and 8th week after trivalent oral poliovirus vaccine (tOPV) was administered. To isolate suspected polioviruses and non-polio enteroviruses, characterize poliovirus subtypes by intratypic differentiation and Sabin vaccine derived poliovirus, real time polymerase chain reaction was applied. Shedding for ≥ 24 weeks was defined as long-term persistence. RESULTS: The mean age of the study population was 28.6 months, while the median age was 24 months. Of the children recruited, majority were in the 25–48 months (n = 12; 46.2%) age category. All the HIV-positive children (n = 10) had mild symptomatic HIV status and did shed vaccine-related polioviruses between weeks 2 and 4 respectively. No participant shed polioviruses for ≥ 6 weeks. CONCLUSIONS: It was evident mildly symptomatic HIV+ children sustain the capacity to clear vaccine-related poliovirus. The oral poliovirus vaccine-2 (Sabin like) that was detected in one HIV-infected child’s stool 6 weeks after the national immunization days was predominantly non revertant. There was no evident prolonged poliovirus shedding among the participants enlisted in the present study. High powered studies are desired to further corroborate these findings. BioMed Central 2017-11-03 /pmc/articles/PMC5670520/ /pubmed/29100529 http://dx.doi.org/10.1186/s13104-017-2843-y Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Hassan, Joanne
Wangai, Laura
Borus, Peter
Khayeka–Wandabwa, Christopher
Karani, Lucy Wanja
Kithinji, Mercy
Kiptoo, Michael
Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children
title Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children
title_full Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children
title_fullStr Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children
title_full_unstemmed Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children
title_short Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children
title_sort vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5670520/
https://www.ncbi.nlm.nih.gov/pubmed/29100529
http://dx.doi.org/10.1186/s13104-017-2843-y
work_keys_str_mv AT hassanjoanne vaccinerelatedpoliovirussheddingintrivalentpoliovaccineandhumanimmunodeficiencyvirusstatusanalysisfromunderfivechildren
AT wangailaura vaccinerelatedpoliovirussheddingintrivalentpoliovaccineandhumanimmunodeficiencyvirusstatusanalysisfromunderfivechildren
AT boruspeter vaccinerelatedpoliovirussheddingintrivalentpoliovaccineandhumanimmunodeficiencyvirusstatusanalysisfromunderfivechildren
AT khayekawandabwachristopher vaccinerelatedpoliovirussheddingintrivalentpoliovaccineandhumanimmunodeficiencyvirusstatusanalysisfromunderfivechildren
AT karanilucywanja vaccinerelatedpoliovirussheddingintrivalentpoliovaccineandhumanimmunodeficiencyvirusstatusanalysisfromunderfivechildren
AT kithinjimercy vaccinerelatedpoliovirussheddingintrivalentpoliovaccineandhumanimmunodeficiencyvirusstatusanalysisfromunderfivechildren
AT kiptoomichael vaccinerelatedpoliovirussheddingintrivalentpoliovaccineandhumanimmunodeficiencyvirusstatusanalysisfromunderfivechildren